SUBSCRIBE
SUBSCRIBE
News   FDA

Aventis Pharma Obtains Additional Approval for Taxoid Antitumor Agent TAXOTERE Injection

October 19, 2005 | 
1 min read
Tokyo (JCN) - Aventis Pharma of the sanofi-aventis Group announced on August 19 that it has obtained additional approval for TAXOTERE Injection, its proprietary taxoid antitumor agent, from the Ministry of Health, Labor and Welfare as of August 18.
FDA Approvals
Sanofi US Sanofi (France)
MORE ON THIS TOPIC
Planning strategy and ways to achieve business goals, searching for new opportunities for high results, direction of career development, the path to great success, man changes direction on signpost.
Gene therapy
FDA Does 180 on Sarepta, Freeing DMD Gene Therapy for Ambulatory Patients
July 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
A concept of unfair social prejudice. The miniature men and a magnifying glass.
Duchenne muscular dystrophy
Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches Probe
July 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Confused businessman stands in front of different arrows . The concept of hard choices.
Regulatory
Drug Pricing Just One Point of Confusion Over New FDA Vouchers
July 28, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
Problems and Challenges. Businessman stands on question mark
Gene therapy
Sarepta’s Future Increasingly Uncertain as FDA Eyes New Study for Elevidys
July 25, 2025
 · 
4 min read
 · 
Tristan Manalac